Ge Wei

Ge (Gina) Wei is a seasoned professional in the field of translational medicine and pharmacology, currently serving as Sr. Director of Translational Pharmacology at Nurix Therapeutics since June 2022. Previous positions include Sr. Director of Translational Medicine at QED Therapeutics and senior roles at Bristol-Myers Squibb, IGNYTA/Roche, and Halozyme Therapeutics, where significant contributions were made in small molecular drug discovery and translational research for various investigational anti-cancer drugs. Ge holds a Ph.D. in Biochemistry and Molecular Genetics from the University of Alabama at Birmingham, as well as master's and bachelor's degrees in Biochemistry from Peking University. Additional professional development includes a Woman in Leadership Executive Program at UC Santa Barbara Extension.